Azitra (AZTR) announced it received a notice from the staff of the NYSE that Azitra was not in compliance with the exchange’s continued listing standards under Section 1003 of the NYSE American Company Guide. Section 1003 requires a listed company to have stockholders’ equity of $4M or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. Azitra is subject to the procedures and requirements of Section 1009 of the NYSE American Company Guide. Azitra has until October 31 to submit a plan of actions it has taken or will take to regain compliance with the continued listing standards by April 1, 2027.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZTR:
- Azitra Inc.’s ATR-04 Study: A Potential Game-Changer for Rash Treatment
- Azitra price target lowered to $4 from $13.32 at Maxim
- Azitra Inc.’s ATR04-484 Study: A Promising Step in Treating EGFRi-Associated Rash
- Azitra Inc Modifies Agreement with Alumni Capital
- Azitra Stock (AZTR) Rockets on Clinical Trial Update